patients with atrioventricular nodal re-entrant paroxysmal supraventricular tachycardia (Denes et al., I973; Rosen et al., I974; Wu et al., I974) . In these earlier studies, the presence of dual atrioventricular nodal pathways was related to the patients' clinical and/or electrocardiographic findings.
Our recent experience suggests that electrophysiological responses suggestive of dual atrioventricular nodal pathways are a common occurrence and often without apparent relation to the patients' clinical or electrocardiographic findings. In this report, we describe our total experience with patients having extrastimulus studies suggestive of dual atrioventricular nodal pathways. Clinical, electrocardiographic, and electrophysiological observations are reported in this group, in order to elucidate further the significance of this interesting electrophysiological phenomenon.
Subjects and methods Forty-one patients out of a total number of 397 patients group.bmj.com on June 22, 2017 -Published by http://heart.bmj.com/ Downloaded from 1070 Denes, Wu, Dhingra, Amat-y-Leon, Wyndham, and Rosen studied with atrial extrastimulus technique between July I971 and July I974 showed electrophysiological evidence of dual atrioventricular nodal pathways. These are the subject ofthe present report. Patients with electrocardiographic evidence of pre-excitation (short PR interval (<O.I2 s), and/or presence of a delta wave) were excluded. Historical, physical, electrocardiographic, and electrophysiological findings were reviewed in each patient. Of these 4I patients, 8 have been the subjects of previous reports (Denes et Electrophysiological studies were performed in the post-absorptive, non-sedated state. All cardiac drugs were discontinued 48 hours before study. Informed consent was obtained from each patient. His bundle electrograms were recorded by a catheter technique (Dhingra, Rosen, and Rahimtoola, I973) . Refractory periods were measured with the atrial extrastimulus method during sinus rhythm, or at a cycle length slightly shorter than sinus (CL1) (Denes et al., 1973) . In 25 patients, the effect of shortening of cycle length on refractory periods was also examined. In these patients, a second paced cycle length (CL2) was selected, which was shorter than CL1, but longer than the cycle length inducing atrioventricular nodal Wenckebach periods.
Definitions
Established criteria for electrocardiographic diagnosis of myocardial infarction and arrhythmias were used (Lipman and Massie, I965; Katz and Pick, 1956) . 'Documented arrhythmias' were defined as spontaneous arrhythmias with electrocardiographic documentation. Two PR intervals were diagnosed when surface electrocardiograms revealed two non-overlapping ranges of PR intervals (Rosen et al., I974) .
Dual atrioventricular nodal pathways were defined with atrial extrastimulus technique. Dual pathway curves were characterized by a sudden jump in H1-H2 at a critical range of A1-A2 coupling intervals (Denes et al., I973; Rosen et al., 1974; Wu et al., I974) . None of these curves conformed to previously described normal atrioventricular nodal curves. The portion of the curve to the right of the jump represented the fast pathway, and to the left, the slow pathway. The slope of the slow pathway could be positive (decrease in H1-H2 with decreasing A1-A2 intervals), flat (no change in H1-H2 with decreasing A1-A2), or negative (increase in H1-H2 with decreasing A1-A2). Though repeated scanning with the atrial test stimuli close to the A1-A2 interval producing the jump frequently demonstrated an overlap of H1-H2 corresponding to the fast and slow pathways, intermediate H1-H2 intervals were not elicited in this zone of overlap (Rosen et al., 1974) . Curve fitting analysis was used in any of the cases where the diagnosis of dual pathways was equivocal (Denes et al., 1973) .
The fast pathway effective refractory period was de- (Fig. IA) , a flat slope in I4 (52%) patients (Fig. iB) , and a positive slope in 5 (i8%) patients (Fig. IC) .
In the I4 patients with smooth curves at CL1, AH intervals during sinus rhythm ranged from 72 to I8o ms (95 ± 28 ms). Atrioventricular nodal effective refractory period could only be measured in 4, and ranged from 245 to 380 ms (309 ± 55 ms). In the remaining I0 patients, atrioventricular conduction was atrial limited. Atrioventricular nodal functional refractory period in the I4 patients ranged from 390 to 530 ms (453 ± 62 ms).
In the I4 patients with dual pathways only at CL2, fast pathway effective refractory period and functional refractory period ranged from 265 to 500 ms (36i ± 68), and 3IO to 590 ms (446 ± 8i ms), respectively. Slow pathway effective refractory period could be measured in 7, and ranged from 300 tO 420 ms (346 ± 59 ms). In the remaining 7 patients, atrioventricular conduction was atrial limited. Slow pathway functional refractory period ranged from 400 to 740 ms (554± III ms).
In the II patients in whom dual pathway curves were obtained at both CL1 and CL2, the effect of decrease in CL on the fast and slow pathway refractory periods could be determined. Mean ± SD CL1 and CL2 in these II patients were, respectively, 768 ± 76 and 64I ± 44 ms. The mean ± SEM fast pathway effective refractory period at CL1 and CL2 were, respectively, 39I ± 29 and 428±37 ms (P <o.o5) ( Fig. 2A and B, and Fig. 4) . The mean fast pathway functional refractory periods at CL1 and CL2 were, respectively, 50I ± 28 and 489 ± 20 ms (NS). The mean slow pathway effective refractory periods at CL1 and CL2 were, respectively, 341 ± 36 and 374 ± 46 ms (P < o.I) ( Fig. 2A and B , and Fig. 4) (1974) recently reported a patient with two PR intervals and dual atrioventricular nodal conduction times and refractory periods, findings strongly suggestive of dual atrioventricular nodal pathways. paroxysmal supraventricular tachycardia and normal PR intervals, suggesting dual atrioventricular nodal pathways. In these previous studies, the demonstration of dual atrioventricular nodal pathways was directly relevant to the patients' clinical or electrocardiographic findings.
The present study suggests that dual atrioventricular nodal pathways are a relatively common electrophysiological finding, being found in approximately io per cent of the patients undergoing extrastimulus testing in our laboratory. Though the patients studied in our laboratory frequently have conduction disease, the demonstration of dual pathways was frequently not anticipated and not always relevant to the patients' clinical or electrocardiographic findings.
In a patient with dual pathways, the ability to demonstrate these pathways depends upon the properties of the two pathways. The following conditions are necessary for the demonstration of dual pathways with atrial extrastimulus technique. i) A fast pathway effective refractory period which is longer than the slow pathway effective refractory period; if the fast pathway had a shorter effective refractory period than the slow pathway, the slow pathway would be concealed. 2) An atrial functional refractory period which is shorter than the slow pathway effective refractory period; if the atria had a longer functional refractory period than the slow pathway effective refractory period, the slow pathway would be concealed.
The inability to demonstrate dual pathways during sinus rhythm in I4 patients of the present series may be explained by the above conditions. Shortening of cycle length decreased the atrial functional refractory period (Denes etal., I974a) , and group.bmj.com on June 22, 2017 -Published by http://heart.bmj.com/ Downloaded from Dual A V nodal pathways 1075 as demonstrated in the present study, prolonged fast pathway effective refractory period. Both of these effects could allow unmasking of a slow pathway with atrial pacing, which was concealed at CL1. This could account for demonstration of dual pathways only at CL2 in some or all of these I4 patients. However, another factor must be considered. It also is possible that dual pathways were not present at longer cycle lengths (sinus rhythm) in these patients, and that non-homogeneity of atrioventricular conduction related to shortening of cycle lengths was a necessary prerequisite for functional dissociation of the atrioventricular node.
We have assumed that the slow pathway is intranodal. Whether the fast pathway is intranodal or extranodal (James tract or other bypass) is not yet clear (Denes, Wu, and Rosen, I974b) . The following fast pathway properties are consistent with an intranodal location. i) An AH during sinus rhythm (fast pathway conduction time) which is within or greater than the normal range of AH intervals. 2) A fast pathway functional refractory period which is within or greater than the normal range for atrioventricular nodal functional refractory period. 3) A fast pathway effective refractory period which is within or greater than the normal range for atrioventricular nodal effective refractory period. 4) An increase in fast pathway effective refractory period with decrease in cycle length, the normal cycle length-refractory period relation of the atrioventricular node (Denes et al., I974a) . Fast pathways in the present series conformed to the properties described above.
If both fast and slow pathways were intranodal, they could reflect either functional longitudinal dissociation, or anatomical septation of the node. Of the 4I patients reported in this study, 22 had atrioventricular nodal dysfunction as manifested by abnormal electrophysiological findings (prolonged conduction times or refractory periods) and/or aetiological factors directly associated with atrioventricular nodal injury (previous diaphragmatic infarction or intracardiac surgery) (De Soyza et al., 1974) . It is possible that in some of the patients, pathological lesions might be responsible for anatomical division of the node into two pathways. In the 3 patients with hypothyroidism, one could postulate myxoedematous infiltration of the atrioventricular node as a possible cause of dual pathways.
The presence of dual atrioventricular nodal pathways predisposes to the occurrence of atrioventricular nodal re-entrant paroxysmal supraventricular tachycardia (Denes et al., I973; Wu et al., I974 ). An atrial premature impulse blocked in the fast pathway may conduct antegradely via the slow pathway, and return to the atria via the fast pathway. Thus, it is not surprising that I7 of the 4I patients with dual pathways had documented episodes of paroxysmal supraventricular tachycardia. In I5 of these I7 patients, atrioventricular nodal re-entrance with the echo phenomenon was induced during atrial premature stimulation. In IO of these i5, sustained atrioventricular nodal re-entrant paroxysmal supraventricular tachycardia could be induced during electrophysiological study.
The following conditions seem to be necessary for the induction of single atrial echoes (due to atrioventricular re-entrance) in a patient with dual pathways. i) An antegrade fast pathway effective refractory period longer than the slow pathway antegrade refractory period. 2) A slow pathway anterograde conduction time long enough for the pathway to recover for retrograde conduction. 3) A final common pathway distal to the fast and slow pathways, so that the impulse can re-enter the fast pathway. 4) Ability for the fast pathway to conduct in retrograde direction. For sustained atrioventricular nodal re-entrant paroxysmal supraventricular tachycardia to develop in these patients, conditions i) to 4) must be met. In addition, there must be a proximal common pathway so that the retrograde fast pathway impulse can re-enter the slow pathway in an antegrade direction. There must also be critical relations between fast and slow pathway conduction times and refractory periods, so that the circus movement is not extinguished. Atrioventricular nodal conduction is much influenced by autonomic nervous influences. Since the necessary relation between fast and slow pathway conduction time and refractory periods appear to be relatively critical for the development of sustained re-entrance, the lack of induction of sustained reentry in the patients with known documented paroxysmal supraventricular tachycardia is not surprising. One has only to postulate that autonomic influences have critically changed refractoriness or conduction time in one or both pathways, and the ability for sustained re-entrance could be lost. The demonstration of dual pathways in 8 patients with paroxysmal palpitation without documented paroxysmal supraventricular tachycardia is intriguing. Though in 4 of the patients, other arrhythmias (ventricular tachycardia and atrial flutter) appeared to relate to palpitation, in the remaining 4, dual pathways were the most striking abnormality of conduction demonstrated. It is our opinion that the demonstration of dual pathways in these 4 suggests that sporadic episodes of atrioventricular nodal reentrant paroxysmal supraventricular tachycardia may account for the history of palpitation. Sixteen of the patients had neither palpitation nor docu-mented paroxysmal supraventricular tachycardia. It is not known whether these i6 patients are at risk for development of clinically significant spontaneous paroxysmal supraventricular tachycardia in the future.
The present study sheds little light on one of the most intriguing questions concerning dual atrioventricular nodal pathways in man: 'Are dual atrioventricular nodal pathways a property of the normal atrioventricular node in a healthy heart ?' Our data in patients without organic heart disease and without paroxysmal supraventricular tachycardia are too limited to answer this question. Our current data suggest that patients with recurrent paroxysmal supraventricular tachycardia without other cardiac abnormality frequently have dual atrioventricular nodal pathways. However, in these patients, it is possible that either congenital or acquired abnormality of atrioventricular nodal function predisposes to longitudinal dissociation of the atrioventricular node into dual pathways.
